Comparative Effectiveness of Linvoseltamab Versus Standard-of-care (SOC) Treatment (tx) in Real-World Patients (pts) in the United States (US) with Triple-Class Exposed (TCE) Relapsed/refractory Multiple Myeloma (RRMM).
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined